CN Patent

CN104395308B — N-[5-(3,5-二氟-苄基)-1h-吲唑-3-基]-4-(4-甲基-哌嗪-1-基)-2-(四氢-吡喃-4-基氨基)-苯甲酰胺的制备方法

Assigned to Nerviano Medical Sciences SRL · Expires 2016-08-24 · 10y expired

What this patent protects

本发明涉及N-[5-(3,5-二氟-苄基)-1H-吲唑-3-基]-4-(4-甲基-哌嗪-1-基)-2-(四氢-吡喃-4-基氨基)-苯甲酰胺的制备方法。本发明的目的还在于该化合物的新固体形式、它们在治疗由蛋白激酶活性失调引起的疾病中的应用以及含有该化合物的药物组合物。

USPTO Abstract

本发明涉及N-[5-(3,5-二氟-苄基)-1H-吲唑-3-基]-4-(4-甲基-哌嗪-1-基)-2-(四氢-吡喃-4-基氨基)-苯甲酰胺的制备方法。本发明的目的还在于该化合物的新固体形式、它们在治疗由蛋白激酶活性失调引起的疾病中的应用以及含有该化合物的药物组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN104395308B
Jurisdiction
CN
Classification
—
Expires
2016-08-24
Drug substance claim
No
Drug product claim
No
Assignee
Nerviano Medical Sciences SRL
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.